Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma - results of the UK HD3 relapse treatment strategy

Shankar, Ananth; Hayward, Janis; Kirkwood, Amy A.; McCarthy, Keith; Hewitt, Martin; Morland, Bruce; Daw, Stephen

doi:10.1111/bjh.12768

Cited by 14 publications

(12 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the patients in our cohort were not the most favorable. Multiple studies have shown remission duration <1 year, presence of extranodal disease, and B symptoms at relapse to be important prognostic factors in relapsed/refractory HL . Likewise, a multivariate analysis of 606 children, adolescents, and young adults with relapsed or refractory HL (median age 23 years, range 3–29 years) who underwent ASCT demonstrated similar results .…”

Section: Discussionmentioning

confidence: 69%

“…The majority of published literatures in pediatric cohorts have employed computed tomography (CT) measurements to assess pretransplant disease status, and data on the predictive value of pretransplant FI in pediatrics are very limited. Based on the adult experience, the treatment approach at the Dana Farber/Boston Children's Cancer and Blood Disorders Center (DF/BC CBDC) has focused on getting patients with relapsed or refractory HL into complete metabolic remission before autologous transplant.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation

Ozuah

Dahmoush

Grant

et al. 2017

Pediatric Blood & Cancer

View full text Add to dashboard Cite

Background: Pretransplant functional imaging (FI), particularly a negative positron emission tomography (PET), is a strong predictor of outcome in adults with relapsed or refractory Hodgkin lymphoma (HL), but data in pediatrics are limited. Methods:The medical records of 49 consecutive pediatric patients, who received autologous transplant at a single institution, were retrospectively analyzed. All patients had either gallium or PET scan before transplant and were conditioned with carmustine, etoposide, cytarabine, and melphalan (BEAM). Deauville scores were retrospectively assigned for patients with PET (score ≥ 4 positive). Conclusion:Our analysis revealed outstanding outcomes for children and adolescents with relapsed/refractory HL. There were too few relapses to identify the predictive value of pretransplant metabolic status, but pediatric patients with relapsed/refractory HL and a negative pretransplant FI had excellent survival.

show abstract

Section: Discussionmentioning

confidence: 69%

Section: Introductionmentioning

confidence: 99%

Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation

Ozuah

Dahmoush

Grant

et al. 2017

Pediatric Blood & Cancer

View full text Add to dashboard Cite

show abstract

“…transplantation and is used either as first line or salvage treatment [1][2][3][4]. The history of allogeneic HSCT goes back to the 1980 s and indications, conditioning regimens, and donor sources have changed enormously since then [5,6].…”

Section: Introductionmentioning

confidence: 99%

“…The Swiss Pediatric Oncology Group (SPOG) M. Ansari 6,7 , M. Beck Popovic 13 , J. P. Bourquin 14 , P. Brazzola 15 , J. Greiner 16 , J. Rössler 12 , F. Schilling 17 , K. Scheinemann 2,8,9 , N. von der Weid 4…”

mentioning

confidence: 99%

Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation—a cohort study

Otth

Schindera

Güngör

et al. 2020

Bone Marrow Transplant

View full text Add to dashboard Cite

Childhood cancer survivors treated with hematopoietic stem cell transplantation are at high risk for pulmonary morbidity and mortality. In this retrospective study we described transplant characteristics of pediatric patients who underwent hematopoietic stem cell transplantation in Switzerland and how these characteristics changed over time, compared self-reported pulmonary outcomes between transplanted and non-transplanted survivors, and investigated risk factors for the reported pulmonary outcomes. As part of the population-based Swiss Childhood Cancer Survivor Study, we sent questionnaires to all ≥5-year childhood cancer survivors diagnosed 1976–2010 at age ≤20 years. We included 132 transplanted survivors and 368 matched non-transplanted survivors. During the study period transplant characteristics changed, with decreasing use of total body irradiation and increased use of peripheral blood stem cells and mismatched and unrelated donors as transplant source. One-fifth of transplanted survivors (20%, 95%CI 13–27%) and 18% of non-transplanted survivors (95%CI 13–21%) reported at least one pulmonary outcome. None of the analyzed factors was significantly associated with an increased risk of pulmonary outcomes in multivariable analysis. We found that pulmonary outcomes were frequently reported in transplanted and non-transplanted childhood cancer survivors, indicating a strong need for long-term pulmonary follow-up care.

show abstract

“…Several studies have suggested extrapolating data on the benefit of HDC and auto-SCT from the literature on adults. 4-7 The aim of this study was to evaluate the outcomes of children and adolescents with relapsed or refractory HL treated with HDC and auto-SCT at our institution. In a resource-limited setting such as ours, outcomes were analyzed in progressive HL to decide whether to continue to offer this mode of therapy to patients.…”

Section: Introductionmentioning

confidence: 99%

Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience

Wali

Saeed

Patrus

et al. 2019

JGO

View full text Add to dashboard Cite

PURPOSE Hodgkin lymphoma is the most common cancer in children, adolescents, and young adults. Overall survival is approximately 80% to 90%. A subset of these patients has refractory disease or experience disease relapse. Conventional salvage therapies and autologous stem-cell transplantation is usually considered the standard of care for these patients. Our analysis reports outcomes in these patients. PATIENTS AND METHODS After institutional review board approval, a retrospective analysis of patients with Hodgkin lymphoma who were up to 18 years of age and who had refractory or relapsed disease at Shaukat Khanum Memorial Cancer Hospital and Research Centre from September 2009 to December 2013 was performed. Patients who underwent high-dose chemotherapy followed by stem-cell rescue were included in this analysis. RESULTS A total of 567 patients with Hodgkin lymphoma registered at the hospital. Sixty of the patients (10.6%) had either primary progressive or refractory disease or relapse after finishing with first-line chemotherapy. High-dose chemotherapy followed by stem cell was administered to 25 of these patients (42%). Thirteen patients (40%) had progressive disease (PD), five (22%) had early relapse, and seven (38%) had late relapse. A number of salvage regimens were used, including etoposide, prednisolone, ifosfamide, and cisplatin; dexamethasone, cytarabine, and carboplatin; and gemcitabine plus vinorelbine. Re-evaluation was performed before taking patients to a high dose, and it showed complete response in 17 patients (68%), partial response in six patients (24%), and PD in two patients (8%). Twenty-one patients (84%) are in remission after transplantation, with two patients (8%) having died as a result of disease progression and two patients (2%) having relapsed after treatment. Overall survival is 92% at 4 years, with event-free survival of 80% at 4 years. CONCLUSION Our retrospective analysis shows good outcomes in patients who had PD or refractory disease. Disease response before transplantation is important in predicting outcomes.

show abstract

Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma - results of the UK HD3 relapse treatment strategy

Cited by 14 publications

References 36 publications

Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation

Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation

Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation—a cohort study

Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience

Contact Info

Product

Resources

About